WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Felanorm, the first generic methimazole oral solution for treating hyperthyroidism in cats. This new medication offers a vital alternative to the existing brand name drug, Felimazole Coated Tablets, first approved in 2009.
A New Treatment Option
Felanorm contains the same active ingredient, methimazole, as Felimazole. It provides an effective treatment for feline hyperthyroidism, a condition where the thyroid gland produces excessive hormones, leading to various health issues. Unlike Felimazole tablets, Felanorm comes in an oral solution, making administration potentially easier for some pet owners.
Prescription and Veterinary Oversight
Felanorm is only available through a prescription from a licensed veterinarian. Diagnosing hyperthyroidism and determining the appropriate treatment requires professional veterinary expertise. Continued monitoring by a vet is also essential, as the disease can progress over time, necessitating dosage adjustments.
Dosage and Safety
Felanorm is supplied in 30 mL or 100 mL bottles and includes a 1 mL dosing syringe. The medication is administered in 2.5 mg increments every 12 hours, with a maximum total dosage of 20 mg per day, not exceeding 10 mg in a single dose.
People administering Felanorm to their cats should wear protective gloves, such as latex or nitrile, and wash their hands with soap and water afterward to avoid exposure to the drug.
Manufacturer and Approval
Norbrook Laboratories Ltd., based in the United Kingdom, sponsors Felanorm. The FDA’s approval ensures that Felanorm meets the necessary standards for safety and efficacy, making it a reliable option for treating hyperthyroidism in cats.
Felanorm Approval: A Leap Forward in Feline Health
The approval of Felanorm marks a significant milestone in veterinary medicine. It provides veterinarians and pet owners with more options for managing hyperthyroidism in cats. This generic solution can potentially reduce the cost of treatment while maintaining the effectiveness of the active ingredient, methimazole.
As with any medication, proper administration and ongoing veterinary supervision are crucial to effectively managing a cat’s health. The introduction of Felanorm underscores the importance of continued innovation in pet healthcare, ensuring that animals receive the best possible treatments available.
With this new option, the FDA continues to support advancements in veterinary medicine, improving the quality of life for pets and peace of mind for their owners.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.